Magnetic resonance imaging radiomic features for recurrent prostate cancer following proton radiation therapy–A pilot study

医学 前列腺癌 前列腺 磁共振成像 活检 放射科 放射治疗 有效扩散系数 核医学 癌症 内科学
作者
Soroush T Bazargani,Allison H. Feibus,Ahmed Elshafei,Mohammed Al‐Toubat,Dheeraj Reddy Gopireddy,Shiva Gautam,Shivon Barwari,Randal H. Henderson,Chandana G. Lall,K.C. Balaji,Mark Bandyk
出处
期刊:Urologic Oncology-seminars and Original Investigations [Elsevier BV]
卷期号:41 (3): 145.e1-145.e5 被引量:3
标识
DOI:10.1016/j.urolonc.2022.10.007
摘要

OBJECTIVE: The role of multiparametric MRI (mp-MRI) for postproton radiation evaluation is unclear. In this pilot study, we characterize the mp-MRI features using the Prostate Imaging-Reporting and Data System (PI-RADS) for recurrent prostate cancer (PCa) following proton radiation therapy. METHODS: After obtaining IRB approval, we identified 163 consecutive cases who underwent MRI-fusion prostate biopsy at our institution from November 2017 to May 2020. This study evaluated patients with prostate cancer (PCa) with biochemical recurrence following proton radiation. Patients were excluded if they had grossly metastatic disease, metal fragments, implanted devices, or with surgically removed prostates. The mpMRI studies were reviewed in depth and scored by 2 fellowship-trained radiologists. Following MRI-fusion biopsy of lesions of interest (LOI), slides were read by fellowship-trained pathologists. RESULTS: We found 14 patients with 16 lesions who met the study inclusion criteria. The median age was 69 years (range 57-79) and median time to biochemical recurrence was 7.3 years (range 3-13). On post-treatment imaging, decreases in prostate size and diffusely decreased T2 signal intensity were observed, making the use of apparent diffusion coefficient (ADC) and early enhancement at dynamic contrast enhanced (DCE) imaging often necessary for diagnosis of disease recurrence. We identified a total of 16 lesions with PIRADS scores of 3 or higher. Of these lesions, there were 5 PIRADS 3 lesions (4/5 (80%) without prostate cancer), 7 PIRADS 4-5 lesions (6 (86%) had high risk Pca), and 4 lesions with unassigned PIRADS scores (100% had high risk cancers). Among the MRI variables, diffusion weighted imaging (DWI) heterogeneity had the strongest association with recurrence of PCa (P < 0.001). CONCLUSIONS: Results of our pilot study showed that the PIRADS scoring system in the postproton radiation therapy setting has some correlations with prostate cancer recurrence; However, the clinical value of these findings are unclear. While definitive PIRADS categorization of lesions demonstrated expected frequency of cancer consistent with the scoring system, all unassigned lesions also harbored malignancy suggesting a cautious approach to PIRADS scoring system in postproton radiation setting. The findings from this study may be validated using a larger cohort.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
龙彦完成签到,获得积分10
1秒前
1秒前
1秒前
科研通AI6.3的应助被鸟儿采纳,获得30
1秒前
王春焦发布了新的文献求助10
1秒前
12发布了新的文献求助10
2秒前
缥缈含双发布了新的文献求助10
2秒前
酷酷的悒发布了新的文献求助10
2秒前
ssc发布了新的文献求助10
2秒前
Maestro_S的应助被洁净念蕾采纳,获得10
4秒前
4秒前
4秒前
5秒前
5秒前
Tin关闭了Tin的文献求助
6秒前
molihuakai的应助被忧心的妙之采纳,获得10
6秒前
7秒前
123完成签到,获得积分10
7秒前
Feny发布了新的文献求助10
8秒前
9秒前
9秒前
10秒前
亦然发布了新的文献求助10
10秒前
Jason发布了新的文献求助10
11秒前
宋智淳发布了新的文献求助10
11秒前
你好完成签到 ,获得积分10
12秒前
NingCp完成签到,获得积分10
12秒前
我愿完成签到,获得积分10
12秒前
yy完成签到,获得积分20
14秒前
昔我往矣发布了新的文献求助10
14秒前
Akim的应助被心晴采纳,获得10
15秒前
16秒前
闪闪的静枫完成签到,获得积分10
16秒前
18秒前
科研通AI65的应助被qianf采纳,获得10
18秒前
19秒前
清秀网络完成签到,获得积分10
19秒前
Redemption发布了新的文献求助10
20秒前
缥缈含双完成签到,获得积分20
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192723
求助须知:如何正确求助?哪些是违规求助? 9579144
关于积分的说明 21863903
捐赠科研通 7792268
什么是DOI,文献DOI怎么找? 3437013
关于科研通互助平台的介绍 2560633
邀请新用户注册赠送积分活动 2483864